ML25155A315
| ML25155A315 | |
| Person / Time | |
|---|---|
| Site: | 11006621 |
| Issue date: | 06/04/2025 |
| From: | Eric Stahl NRC/OIP |
| To: | Patton J SHINE Technologies |
| References | |
| Download: ML25155A315 (1) | |
Text
2.22 Terabecquerels (TBq)
Lutetium-177, in a liquid solution, not to exceed 2.22 TBq, for medical research and development, clinical trials, and human medical use.
Neither this license nor any right under this license shall be assigned or otherwise transferred in violation of the provisions of the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974.
This license is subject to the right of recapture or control by Section 108 of the Atomic Energy Act of 1954, as amended, and to all the other provisions of said Acts, now or hereafter in effect and to all valid rules and regulations of the U.S.
Nuclear Regulatory Commission.
ERIC STAHL Digitally signed by ERIC STAHL Date: 2025.06.04 11 :42:21 June 4, 2025
medical research and development, clinical trials, and human medical use medical research and development, clinical trials, and human medical use) medical research and development, clinical trials, and human medical use medical research and development, clinical trials, and human medical use medical research and development, clinical trials, and human medical use medical research and development, clinical trials, and human medical use medical research and development, clinical trials, and human medical use medical research and development, clinical trials, and human medical use